Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05641207 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05641207 · ClinicalTrials.gov record · last posted 2026-08-21

A Clinical Evaluation of the RheOx Bronchial Rheoplasty System

StatusCompleted
PhaseNot applicable
Started2023-05-18
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This is a prospective, multicenter, single arm and open-label clinical trial to evaluate the performance, effectiveness and safety of RheOx™ system in the treatment of the symptoms of chronic bronchitis in adult moderate to severe COPD patients.

Protocol amendment history 3 changes detected by DataLookout

2026-08-22
notable
Trial completed
2026-08-22
critical
Primary completion pushed: 2025-08 → 2026-04-30
2026-08-22
minor
Completion pushed: 2025-11 → 2026-06-30
Trial Details
NCT Number NCT05641207
Lead Sponsor Energenx Medical LTD.
Conditions Chronic Bronchitis, Chronic Obstructive Pulmonary Disease
Enrollment 40 participants
Start Date 2023-05-18
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-21